On Monday, shares of YY Inc (ADR)(NASDAQ:YY), subtract -2.37% and shut at $44.03 inside the end purchasing and offering session. The last exchanging scope of the stock ranges amongst $41.18 and $46.38. YY Inc. (YY) (“YY” or the “Company”), a live streaming platform, recently declared its unaudited financial results for the third quarter of 2016.
Third Quarter 2016 Highlights
Net revenues raised by 40.3% to RMB2,089.8 million (US$313.4 million) from RMB1,490.0 million in the corresponding period of 2015.
Net income attributable to YY raised by 155.8% to RMB400.0 million (US$60.0 million) from RMB156.4 million in the corresponding period of 2015.
Non-GAAP net income attributable to YY raised by 83.7% to RMB435.6 million (US$65.3 million) from RMB237.1 million in the corresponding period of 2015.
“We are extremely happy to have achieved solid results this quarter with both top- and bottom-line growth across the board,” said Mr. Zhou Chen, Chief Executive Officer of YY. “This growth was mainly driven by the robust 54.5% year-over-year growth in our live streaming business, which was made possible through the successful execution of our business and content strategy. Importantly, we continued to focus on the development of PUGC (Professionally-curated User Generated Content) and PGC. In the third quarter of 2016, we launched a new relationships program and further developed our sports content. In Addition To, Huya broadcasting continues to increase its content offerings for mobile game broadcasting and broaden its popularity. Going forward, we will continue to strengthen our content to meet the ever evolving demands of YY’s 98.0 million PC MAU and 53.4 million mobile MAU in the third quarter of 2016. We believe in our ability to build a comprehensive content ecosystem across our two live streaming platforms, YY Live and Huya broadcasting, and are confident that we have the right strategy in place to further fortify our position as China’s leading interactive, live streaming platform.”
Shares of Zoetis Inc (NYSE:ZTS), added 0.22% and shut at $50.00 inside the last exchanging session. The rest of the purchasing and offering scope of the stock levels among $49.75 and $50.15. The association’s commercial center capitalization is $25.03 Billion with the general uncommon loads of 494.24 million. Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States and internationally. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. The company also provides medicated feed additives that offer medicines to livestock; veterinarian solutions for anesthesia, pain administration, and the diagnosis of diabetes; and other pharmaceutical products, counting pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. In addition, it offers other product categories comprising nutritionals and agribusiness services, in addition to products and services in complementary areas consisting of biodevices, diagnostics, and genetics.